BIOTECHNOLOGY VALUE FUND L P 13D/13G Filings for Celcuity Inc. (CELC)

BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Celcuity Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-06-10
5:01 pm
Purchase
2024-05-3013GCelcuity Inc.
CELC
BIOTECHNOLOGY VALUE FUND L P3,466,000
9.900%
3,466,000increase
(New Position)
Filing